Sperm Quality on GLP-1s: What the Clinical Trials Actually Show
The ENDO 2026 meta-analysis from Warwick Medical School reviewed every published RCT on GLP-1 receptor agonists and male reproductive function.
The Data
The headline: GLP-1s do not harm sperm production and may improve it. Trial-by-trial breakdown: a 24-week semaglutide study showed improved sperm morphology (shape) and maintained testosterone and gonadotropins. A liraglutide maintenance study showed improved sperm concentration and total count.
What This Means for You
A 16-week liraglutide trial in functional hypogonadism showed increased total testosterone, LH, and FSH — confirming the improvements come from restored natural production, not external hormones. Compare this to TRT, which causes 60.6% decrease in sperm concentration and is used as a male contraceptive in some countries. For men planning families now or in the future, GLP-1 treatment is the fertility-preserving choice..
The Practical Application
.
Providers Worth Considering
Compare Men's Health Providers
Find providers that understand male-specific GLP-1 treatment needs.
View Providers →